Shares of railroad operator Kansas City Southern slipped Monday as a UBS analyst downgraded the stock to “Neutral,” saying while the stock is still a good one for investors, it no longer warrants a “Buy” rating.

The Distilled Spirits Council of the United States Inc., whose members include Bacardi USA Inc. and Brown-Forman Corp., spent more than $1.2 million in the second quarter lobbying on drunk driving prevention and other issues, according to a recent disclosure form.

Children picking tobacco in the fields of Malawi for consumers far beyond the African country’s borders are being poisoned as they absorb up to two cigarette packs’ worth of nicotine each day, a children’s rights organization said Monday,

NEW YORK—-In a special report released today, Fitch Ratings says revenue trends in many regional Native American gaming markets in California will continue to deteriorate through the first half of 2010, with a recovery expected to begin in the second half of the year.

MINNEAPOLIS—-MoneyGram International , a leading global money transfer company, today announced an agreement with Shinhan Bank, a leading national bank in South Korea and part of the Shinhan Financial Group , to offer MoneyGram money transfer services across the bank’s network of 850 branch locations.

U.S. stocks rose to 10-month highs on Monday, led by financial and energy shares as investors extended a four-day string of gains on optimism about economic recovery.

Investors are holding on to their optimism about the U.S. economy, sending stocks to fresh 2009 highs. Market indicators rose about 0.5 percent in midday trading Monday, following a surge in overseas markets and extending a big advance from last week.

Shares of American Capital Ltd. tumbled on Monday after Standard & Poor’s Ratings Services lowered debt ratings for the investment firm, citing concerns over debt and earnings performance.

Shares of railroad operator Kansas City Southern slipped Monday as a UBS analyst downgraded the stock to “Neutral,” saying while the stock is still a good one for investors, it no longer warrants a “Buy” rating.

Shares of pharmaceutical research contractor Parexel International rose Monday on higher expectations for the company’s recently acquired ClinPhone business.